Medivation Inc (MDVN)

81.44
0.02 0.02
NASDAQ : Health Care
Prev Close 81.42
Open 81.44
Day Low/High 81.43 / 81.48
52 Wk Low/High 26.41 / 63.34
Volume 7.20M
Avg Volume 4.26M
Exchange NASDAQ
Shares Outstanding 165.93M
Market Cap 13.51B
EPS 1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

After FDA Approval, Merck Posts Better-Than-Expected Earnings

After FDA Approval, Merck Posts Better-Than-Expected Earnings

A day after winning approval for a cancer drug, Merck posts earnings and sales that beat consensus estimates.

What to Watch in Sanofi's Third-Quarter Results

What to Watch in Sanofi's Third-Quarter Results

Slower declines in diabetes drug sales and an acceleration in new oncology treatment Praluent are key to a good quarter for the French drugs maker.

Investor's Guide to This Week's Clovis, Tesaro Ovarian Cancer Drug Updates

Investor's Guide to This Week's Clovis, Tesaro Ovarian Cancer Drug Updates

A cancer research meeting beginning on Friday will provide investors with an opportunity to inspect updated clinical data on two competing PARP inhibitors from Clovis Oncology and Tesaro.

Vigorous M&A Activity Signals Economic Health

Vigorous M&A Activity Signals Economic Health

Despite markets at record highs, companies are satisfying their appetites to grow and find value by buying others.

Pfizer Completes Acquisition Of Medivation

Pfizer Completes Acquisition Of Medivation

Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Medivation, Inc.

Read Scraps Pfizer Break-Up as Megadeals Escape Its Grasp

Read Scraps Pfizer Break-Up as Megadeals Escape Its Grasp

The company has spent $600 million weighing a potential breakup.

Takeover Chatter Around Clovis May Be Overdone

Takeover Chatter Around Clovis May Be Overdone

Rumors are swirling about Big Pharma interest in the cancer drug developer, but the validity of such theories is questioned by at least some company followers.

Pfizer Announces Expiration Of HSR Waiting Period For Proposed Acquisition Of Medivation

Pfizer Announces Expiration Of HSR Waiting Period For Proposed Acquisition Of Medivation

Pfizer Inc. (NYSE: PFE) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended has expired with respect to Pfizer's pending acquisition of Medivation, Inc.

New Setback for Sanofi's Lantus Increases Need for M&A

New Setback for Sanofi's Lantus Increases Need for M&A

UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces An Investigation Of The Board Of Directors Of Medivation, Inc.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces An Investigation Of The Board Of Directors Of Medivation, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Medivation, Inc.

Medivation Proxy Shows Pfizer Battled Four Bidders to Seal a Deal

Medivation Proxy Shows Pfizer Battled Four Bidders to Seal a Deal

So says a proxy filing made after trading on Tuesday, as a couple of suitors included contingent value rights in their bids for the marketer of prostate cancer drug, Xtandi.

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street

There are too many companies in just about every sector of this market, Cramer says.

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Regarding Whether The Sale Of Medivation, Inc. For $81.50 Per Share Is Fair To Shareholders

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Regarding Whether The Sale Of Medivation, Inc. For $81.50 Per Share Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Medivation, Inc.

Portfolio Manager: Is Pfizer Acquiring Too Quickly?

Portfolio Manager: Is Pfizer Acquiring Too Quickly?

Pfizer's second acquisition this week could add risk. Some retailers attract portfolio managers.

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business

Pfizer is making another acquisition.

Why Pfizer's Latest Deal Could Send Its Shares Soaring

Why Pfizer's Latest Deal Could Send Its Shares Soaring

The acquisition of Medivation gives the pharma giant a top-selling oncology drug and an immediate profit boost.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

Pfizer buys antibiotics business from AstraZeneca; Tesla unveils Model S version that can go 300 miles on a single charge; U.S. stock futures rise slightly.

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Regarding Whether The Sale Of Medivation, Inc. To Pfizer Inc. Is Fair To Shareholders

INVESTOR ALERT: Levi & Korsinsky, LLP Announces An Investigation Regarding Whether The Sale Of Medivation, Inc. To Pfizer Inc. Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Medivation, Inc.

Medivation (MDVN) Stock Downgraded After Pfizer Deal

Medivation (MDVN) Stock Downgraded After Pfizer Deal

Medivation's (MDVN) stock rating was cut by several firms on Tuesday morning after the company agreed to be acquired by Pfizer (PFE) for $14 billion yesterday.

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Earnings season is far from over, Cramer says, and the Fed chief gives a major speech Friday.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Market Keeps Chasing Its Own Tail

Stocks travel a good distance just to end up nowhere.

Stocks Waver as Investors Wait for Fed Clarity

Stocks Waver as Investors Wait for Fed Clarity

Wall Street will get more clues on the Fed's rate hike plans later this week, but uncertainty over what they might be led to jittery trading on Monday.

Stocks Struggle for Direction as Jackson Hole Conference Looms

Stocks Struggle for Direction as Jackson Hole Conference Looms

Stocks fluctuate Monday afternoon as a selloff in crude oil hits the energy sector and Federal Reserve speeches at the end of the week leave investors wary.